In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

The drug, known as VIP36, targets the body’s cannabinoid receptor type 1 (CB1). It was found to be effective in three different animal models for pain and does not appear to cause the harmful side ...

Drug A killed all the rats ... Indeed, given that problems exist because scientists must extrapolate from animal models to humans, one might think there are good scientific reasons for preferring ...

As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works alone rather than in combination with another drug called ritonavir. But ...

1). The first-of-its-kind system alleviates the need to fully rely on faulty animal-testing models and is designed to better predict which drug candidates will work safely in humans, eliminating ...

"These results not only confirm in-vitro observations in aggressive, androgen-independent human prostate cancer cells but also represent a game-changing discovery in animal models. We are seeing a ...